Health Ministry Clarifies Gavi Co-Financing, Celebrates Vaccine Leadership

By Ibrahim S. Bangura

Sierra Leone’s Minister of Health, Dr. Austin Demby, has reaffirmed the country’s leadership in immunization and neonatal care while addressing recent concerns about its co-financing obligations with Gavi, the Vaccine Alliance. Speaking at a press conference held on August 11, 2025, at the Ministry of Health’s Conference Hall in the Youyi Building, Dr. Demby emphasized transparency, public trust, and continued progress in life-saving health programs.

Dr. Demby proudly announced that Sierra Leone has maintained over 90% vaccine coverage for five consecutive years, with 2025 on track to uphold this achievement. “While other countries struggle with 50–70% coverage, we’ve consistently surpassed 90%,” he said, crediting the dedication of health workers reaching remote communities.

Recent milestones include HPV Vaccine rollout: 84,000 girls vaccinated in weeks, exceeding the 50,000 targets; and Malaria Vaccine: 70% coverage nationwide.

These accomplishments have positioned Sierra Leone as a continental leader in immunization, attracting global recognition and partnerships.

Responding to a press statement by advocacy group Health Alert, which suggested a vaccine shortage due to a Gavi reminder letter, Dr. Demby clarified that Sierra Leone’s 2025 co-financing obligation of $823,000 is being met ahead of the August 31 deadline. “This caused undue worry among families,” he said, assuring the public that payments are nearly complete and vaccine supplies remain secure.

Gavi, through UNICEF, recently commended Sierra Leone for consistently meeting its obligations. This reliability has earned the country a $17.7 million grant to support vaccine needs for 2025–2026.

Dr. Demby also noted that the Minister of Finance has prioritized health in the national budget, second only to defense, ensuring timely payments despite fiscal constraints. “This is a life-saving priority,” he affirmed.

Sierra Leone’s global influence was highlighted when Gavi’s CEO visited the country amid a funding shortfall caused by reduced donor contributions. President Julius Maada Bio responded by advocating for Gavi on the international stage and delivering the keynote address at its replenishment meeting.

“Every Sierra Leonean should be proud,” Dr. Demby said, noting that the country’s vaccine expertise and program design are admired worldwide.

Dr. Demby urged civil society groups to verify information with the Ministry before publishing. “Provide context,” he advised, emphasizing that collaboration is key to maintaining public trust. He praised media outlets that sought clarification, allowing the Ministry to prevent misinformation.

The press conference also celebrated Sierra Leone’s progress in neonatal care. The country recorded a 90% national survival rate in Special Care Baby Units (SCBUs) during the first half of 2025. The JMB Pediatric Center of Excellence, which treats the most critical cases, achieved a 74% survival rate.

Dr. Demby explained that the lower rate reflects the severity of cases, not a lack of effort, and stressed the importance of early referrals. He thanked frontline health workers, the Directorate of Reproductive Health, and partners including UNICEF, UNFPA, UKAID, and WHO.

A detailed report on SCBU outcomes will be shared with the media to reinforce transparency and public engagement.

As Sierra Leone continues to lead in immunization and neonatal care, Dr. Demby called for collective effort to sustain progress. “Together, we ensure every citizen benefits from a robust immunization program,” he said, inviting questions and dialogue.

The press conference underscored Sierra Leone’s resilience, global leadership, and unwavering commitment to health equity and excellence.